<DOC>
	<DOCNO>NCT02255266</DOCNO>
	<brief_summary>This study conduct Europe . The aim study investigate Long-Term Effectiveness Liraglutide Treatment Type 2 Diabetes daily Practice .</brief_summary>
	<brief_title>Long-Term Effectiveness Liraglutide Treatment Type 2 Diabetes Daily Practice</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Subjects age 18 year per VictozaÂ® SmPC par.4.2 5.1 diagnosed type 2 diabetes receive first prescription liraglutide 2011 None . Available data eligible patient center , include</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>